Journal article

Metabolic health, obesity and 9-year incidence of peripheral arterial disease: The DESIR study

Michael R Skilton, Jaye PF Chin-Dusting, Anthony M Dart, Laima Brazionis, Olivier Lantieri, Kerin O'Dea, Beverley Balkau

Atherosclerosis | ELSEVIER IRELAND LTD | Published : 2011


Funding Acknowledgements

The D.E.S.I.R. study is supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma and sanofi-aventis, and by INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante), Cohortes Sante TGIR, the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche and Topcon.M.R.S., J.P.F.C., and A.M.D. were supported by fellowships from the National Health and Medical Research Council (NHMRC) Australia.